|
1） |
Bibbo C, Goldberg JW. Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot Ankle Int. 2004 May；25 (5)：331-335. |
|
2） |
Giles JT, Bartlett SJ, Gelber AC, Nanda S, Fontaine K, Ruffing V, Bathon JM. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum. 2006 Apr 15；55 (2)：333-337. |
|
3） |
den Broeder AA, Creemers MC, Fransen J, de Jong E, de Rooij DJ, Wymenga A, de Waal-Malefijt M, van den Hoogen FH. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for antitumor necrosis factor；A large retrospective study. J Rheumatol. 2007 Apr；34 (4)：689-695. |
|
4） |
Hirao M, Hashimoto J, Tsuboi H, Nampei A, Nakahara H, Yoshio N, Mima T, Yoshikawa H, Nishimoto N. Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab. Ann Rheum Dis. 2009 May；68 (5)：654-657. |
|
5） |
Kawakami K, Ikari K, Kawamura K, Tsukahara S, Iwamoto T, Yano K, Sakuma Y, Tokita A, Momohara S. Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers； Perioperative interruption of tumour necrosis factor-alpha blockers decreases complications？ Rheumatology (Oxford). 2010 Feb；49 (2)：341-347. |
|
6） |
Hirano Y, Kojima T, Kanayama Y, Shioura T, Hayashi M, Kida D, Kaneko A, Eto Y, Ishiguro N. Influences of anti-tumour necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis. Clin Rheumatol. 2010 May；29 (5)：495-500. |
|
7） |
Momohara S, Kawakami K, Iwamoto T, Yano K, Sakuma Y, Hiroshima R, Imamura H, Masuda I, Tokita A, Ikari K. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol. 2011 Oct；21 (5)：469-475. |
|
8） |
Suzuki M, Nishida K, Soen S, Oda H, Inoue H, Kaneko A, Takagishi K, Tanaka T, Matsubara T, Mitsugi N, Mochida Y, Momohara S, Mori T, Suguro T. Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents； A report from the Committee on Arthritis of the Japanese Orthopaedic Association. J Orthop Sci. 2011 Nov；16 (6)：778-784. |
|
9） |
Kubota A, Nakamura T, Miyazaki Y, Sekiguchi M, Suguro T. Perioperative complications in elective surgery in patients with rheumatoid arthritis treated with biologics. Mod Rheumatol. 2012 Nov；22 (6)：844-848. |
|
10） |
Bongartz T, Halligan CS, Osmon DR, Reinalda MS, Bamlet WR, Crowson CS, Hanssen AD, Matteson EL. Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum. 2008 Dec 15；59 (12)
：1713-1720. |
|
11） |
Scherrer CB, Mannion AF, Kyburz D, Vogt M, Kramers-de Quervain IA. Infection risk after orthopedic surgery in patients with inflammatory rheumatic diseases treated with immunosuppressive drugs. Arthritis Care Res (Hoboken). 2013 Dec；65 (12)：2032-2040. |
|
12） |
Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Ustianowski AP, Helbert M, Watson KD, Lunt M, Symmons DP. Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy；Results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2011 Oct；70 (10)：1810-1814. |
新検索ページはこちら
ログイン
お問い合わせ
書誌情報
